NCT06890546View on ClinicalTrials.gov

Nigella Sativa Supplementation in Hyperlipidemia Treatment

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2025

Conditions
HyperlipidaemiaHyperlipidemia
Interventions
DIETARY_SUPPLEMENT

Nigella Sativa Oil capsule

8 weeks 2 x 900 mg Nigella Sativa oil capsule daily

BEHAVIORAL

Diet

Low calorie diet intervention

Trial Locations (1)

Unknown

İstanbul Bilgi University, Istanbul

All Listed Sponsors
lead

Istanbul Bilgi University

OTHER

NCT06890546 - Nigella Sativa Supplementation in Hyperlipidemia Treatment | Biotech Hunter | Biotech Hunter